MS1943 |
| Katalog-Nr.GC39407 |
MS1943 ist ein erstklassiger, oral bioverfÜgbarer EZH2-selektiver Abbauer mit einem IC50 von 120 nM. MS1943 reduziert die EZH2-Proteinspiegel in zahlreichen dreifach negativen Brustkrebs (TNBC) und anderen Krebs- und nicht krebsartigen Zelllinien signifikant. MS1943 blockiert effektiv die Proliferation mehrerer TNBC- und anderer Krebszelllinien.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2225938-17-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
MS1943 is a first-in-class, orally bioavailable EZH2 selective degrader, with an IC50 of 120 nM. MS1943 significantly reduces EZH2 protein levels in numerous triple-negative breast cancer (TNBC) and other cancer and noncancerous cell lines. MS1943 effectively blocks proliferation of multiple TNBC and other cancer cell lines[1].
[1]. Ma A, et al. Discovery of a first-in-class EZH2 selective degrader.Nat Chem Biol. 2020 Feb;16(2):214-222.
Average Rating: 5 (Based on Reviews and 33 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *